GLP-1 Medication in New York City: Telehealth Access, Costs, and How to Get Started

GLP-1 medications are now accessible across New York City through telehealth platforms that connect residents to licensed providers and licensed compounding pharmacies without requiring an in-person visit.

*Compounded semaglutide and tirzepatide are not FDA-approved. This article is for informational purposes only and does not constitute medical advice. Results vary. Consult a licensed healthcare provider before starting any medication.*

---

New Yorkers move fast, and healthcare access has not always kept up. Specialist appointments in Manhattan can mean weeks-long waits, and finding time for in-person visits is a real obstacle for anyone managing a demanding schedule. GLP-1 receptor agonists, which include semaglutide and tirzepatide, are among the most clinically significant advances in weight management medicine in decades. And for New York City residents, access through telehealth has never been simpler.

Telehealth platforms like Prescriva let you work with a licensed provider, complete your evaluation, and start treatment entirely online. No commuting to a clinic, no waiting rooms, no referrals required.

---

What GLP-1 Medications Are Available in New York City?

Two GLP-1 medications are widely used for weight management in New York and across the country:

Semaglutide is the active ingredient in Ozempic (FDA-approved for type 2 diabetes) and Wegovy (FDA-approved for chronic weight management). It works by mimicking a gut hormone that signals fullness, slows gastric emptying, and reduces appetite through pathways in both the gut and the brain. It is administered as a once-weekly subcutaneous injection.

Tirzepatide is a dual GIP/GLP-1 receptor agonist and the active ingredient in Mounjaro and Zepbound. By activating two complementary receptor pathways, it has produced some of the strongest average weight loss results in the clinical trial literature to date. It is also administered weekly.

Through telehealth, New York City residents can access compounded versions of both medications. Compounded semaglutide and tirzepatide are prepared by licensed 503A compounding pharmacies and dispensed under direct clinician supervision. These are not FDA-approved finished pharmaceutical products, but they provide a legal, medically supervised way to access these active pharmaceutical ingredients outside the brand-name supply chain, at a substantially lower cost.

---

Do You Need an In-Person Appointment in New York?

No. New York State recognizes telehealth as a legitimate standard of care. Under New York's telehealth laws, licensed providers can establish a valid patient-provider relationship and prescribe medication via synchronous video or audio consultation, provided the care meets applicable clinical and regulatory standards.

This means your health intake, provider evaluation, and prescription can all happen online. Prescriva's intake process is structured to meet New York State requirements, with licensed providers conducting real-time clinical reviews through a compliant care model.

For New York City residents, this removes the biggest practical barrier to starting treatment: getting to an appointment in the first place.

---

What Does GLP-1 Medication Cost in New York City?

Cost is one of the most common questions, and the difference between brand-name and compounded options is significant.

Brand-name medications (without insurance):

• Ozempic: approximately $900 to $1,100 per month
• Wegovy: approximately $1,300 to $1,500 per month
• Zepbound (tirzepatide): approximately $1,000 to $1,200 per month

Most commercial health plans require strict prior authorization for GLP-1 medications prescribed for weight management, and many patients in New York end up paying out of pocket regardless of their coverage tier.

Compounded semaglutide and tirzepatide via Prescriva:

• Compounded semaglutide: starting around $199 to $299 per month
• Compounded tirzepatide: starting around $249 to $349 per month

Pricing includes the medication, supplies, and ongoing provider oversight. There are no hidden fees or surprise charges.

Compounded medications are not the same product as brand-name Ozempic, Wegovy, Mounjaro, or Zepbound. They are prepared by a licensed 503A pharmacy with the same active pharmaceutical ingredient but are not FDA-approved finished products and have not been individually studied in their own clinical trials. For people who cannot access or afford brand-name versions, compounded options provide a medically supervised alternative at a fraction of the cost.

---

What Does the Research Say About Telehealth-Delivered GLP-1 Care?

Telehealth delivery of GLP-1 medications has a growing evidence base. A 2026 real-world study drawing on a cohort of approximately 4,500 patients, with 655 followed through week 68, found mean body weight reduction of 16.6% among those tracked to 68 weeks, with a safety profile consistent with Phase 3 clinical trial data. [1] Individual results vary, but the evidence supports telehealth as a clinically effective model for GLP-1-assisted weight management when paired with structured provider oversight.

The clinical trials for semaglutide (STEP 1 through STEP 5) and tirzepatide (SURMOUNT-1 through SURMOUNT-4) provide the foundational efficacy data. STEP 1, published in the New England Journal of Medicine in 2021, found that participants receiving semaglutide 2.4 mg weekly lost a mean of 14.9% of body weight over 68 weeks, compared to 2.4% with placebo. [2] SURMOUNT-1, published in 2022, found mean weight reduction of 20.9% with tirzepatide 15 mg over 72 weeks. [3]

These numbers represent averages across clinical trial populations. Real-world results vary based on starting weight, lifestyle factors, medication adherence, and individual biology. Your provider can give you a realistic picture based on your specific health profile.

---

How the Process Works

Getting started takes about 10 to 15 minutes.

Step 1: Complete your health intake online. Answer questions about your medical history, current medications, weight history, and health goals. Your provider uses this information to determine whether treatment is appropriate for you.

Step 2: A licensed provider reviews your intake. A clinician reviews your submission and determines whether a GLP-1 medication is the right fit. If you qualify, they issue a prescription to a licensed compounding pharmacy.

Step 3: Your medication ships to your NYC address. The pharmacy prepares your medication and ships it directly to you. Most orders arrive within a few business days, with all supplies included.

Step 4: Ongoing monitoring and dose adjustments. Prescriva's model includes regular follow-up to track your progress, guide dose titration, and support you through any questions that come up along the way.

---

Who Qualifies for GLP-1 Treatment?

Most programs, including Prescriva, follow standard clinical criteria aligned with FDA guidelines:

• BMI of 30 or higher (obesity classification), OR
• BMI of 27 or higher with at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol

Standard exclusions include a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN 2), active pancreatitis, or current pregnancy. Your provider reviews your full history during the evaluation.

You do not need to assess your eligibility in advance. That is what the provider evaluation is for.

---

Why GLP-1 Demand Is High in New York City

New York City has a higher-than-average rate of obesity among adults. According to the New York City Department of Health, roughly 22% of adults in the five boroughs are classified as obese, with rates substantially higher in certain neighborhoods in the Bronx, Brooklyn, and Queens. Nationally, over 40% of adults meet criteria for obesity.

GLP-1 medications address obesity as a chronic metabolic condition, not a lifestyle failure. Research published in Obesity Reviews has established that obesity involves persistent hormonal dysregulation including elevated ghrelin (the hunger hormone), reduced peptide YY and GLP-1 (satiety signals), and a lowered metabolic set point that drives weight regain after caloric restriction. [4] GLP-1 medications work by targeting these pathways directly.

For New Yorkers who have tried diet and exercise without durable results, this framing matters: the biology of obesity is working against you, and medication addresses that biology rather than asking willpower to override it.

---

Frequently Asked Questions

Is compounded semaglutide legal in New York?

Yes. Compounded semaglutide prepared by a licensed 503A compounding pharmacy and prescribed by a licensed provider is legal in New York. These medications are not FDA-approved finished products. The pharmacies that prepare them operate under state and federal pharmacy law, and each prescription must be issued by a licensed clinician based on individual patient evaluation.

How long does it take to get started with GLP-1 medication in New York City?

Most patients receive a provider decision within 24 to 72 hours of completing their health intake. Once your prescription is issued, medication typically arrives within a few business days. From intake to first injection, the process commonly takes five to seven days.

Does Prescriva serve patients across all five boroughs?

Yes. Prescriva is a telehealth platform licensed to serve patients across New York State, including Manhattan, Brooklyn, Queens, the Bronx, and Staten Island. Because care is delivered online, your borough or zip code does not affect access or pricing.

What is the difference between compounded and brand-name GLP-1 medication?

Brand-name medications like Ozempic, Wegovy, Mounjaro, and Zepbound have completed the FDA approval process as finished pharmaceutical products. Compounded semaglutide and tirzepatide are prepared by licensed 503A pharmacies using the same active pharmaceutical ingredient, but the finished compounded products are not FDA-approved and have not been studied in their own clinical trials. Both require a valid prescription from a licensed provider. For a detailed comparison, see [how compounded semaglutide compares to Ozempic](/resources/compounded-semaglutide-vs-ozempic).

Can I get GLP-1 medication if I have insurance in New York?

Possibly, but insurance coverage for GLP-1 medications prescribed for weight loss remains inconsistent across plans. Many commercial insurers require prior authorization, and approvals are not guaranteed. New York Medicaid does cover some GLP-1 medications for qualifying members. If insurance coverage does not apply or is denied, compounded options offer a substantially lower out-of-pocket cost without requiring insurance approval.

---

Learn More

• [How to get a GLP-1 prescription online](/resources/how-to-get-glp1-prescription-online)
• [Compounded semaglutide costs in 2026](/resources/compounded-semaglutide-cost-2026)
• [Compounded tirzepatide costs in 2026](/resources/compounded-tirzepatide-cost-2026)
• [Who qualifies for GLP-1 medications](/resources/who-qualifies-for-glp1-medications)
• [Is compounded semaglutide safe?](/resources/is-compounded-semaglutide-safe)

---

Sources

1. Tchang B et al. Real-world outcomes with telehealth-delivered semaglutide for weight management. *Obesity.* 2026. [PMID 41367196](https://pubmed.ncbi.nlm.nih.gov/41367196/)
2. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. *N Engl J Med.* 2021;384(11):989-1002. [PMID 33567185](https://pubmed.ncbi.nlm.nih.gov/33567185/)
3. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. *N Engl J Med.* 2022;387(3):205-216. [PMID 35658024](https://pubmed.ncbi.nlm.nih.gov/35658024/)
4. Sumithran P, Proietto J. The defence of body weight: a physiological basis for weight regain after weight loss. *Clin Sci.* 2013;124(4):231-241. [PMID 23126426](https://pubmed.ncbi.nlm.nih.gov/23126426/)

---

*Compounded semaglutide and tirzepatide are not FDA-approved. This content is for informational purposes only and does not constitute medical advice. Individual results vary. Consult a licensed healthcare provider before starting any medication or treatment program. Care at Prescriva is delivered by independently licensed providers, not by Prescriva LLC, doing business as Prescriva, which is a management services organization.*